Reply to B. Zhao et al

Affiliations

¹ Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Comment

Mei-Yin C Polley et al. J Clin Oncol. 2023.

. 2023 Feb 1;41(4):934-935.

doi: 10.1200/JCO.22.01874. Epub 2022 Oct 3.

¹ Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

No abstract available

Comment on

Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors.
Zhao B, Wu J, Li H, Ma W. Zhao B, et al. J Clin Oncol. 2023 Feb 1;41(4):933-934. doi: 10.1200/JCO.22.01492. Epub 2022 Oct 3. J Clin Oncol. 2023. PMID: 36191285 No abstract available.